Press releases

All press releases published by Fagron are available on this page.

Investors Press releases

Fagron reports 19% topline growth, 11% increase in REBITDA and free cash flow of €91 million for 2022

Disclosure of notifications received from Active Ownership Corporation S.à r.l. and from AOC Pharma S.à r.l.

Fagron delivers topline growth of 21.5% to €173 million

Fagron launches excipients line DiluCap – making capsule formulation easier and more reliable

Fagron commits to set science-based emission reduction targets

Disclosure of notification received from Templeton Investment Counsel, LLC

Disclosure of received notification of Kabouter Management LLC

Disclosure of received notification from The Goldman Sachs Group, Inc. and NN Group N.V.

Fagron delivers strong topline growth of 18.8% and an increase in REBITDA of 13.1% for the first half of 2022

Fagron expands its US sterile compounding footprint with East coast acquisition